Literature DB >> 10818397

Clinical implications of the ovarian/endometrial renin-angiotensin-aldosterone system.

E Hassan1, G Creatsas, G Mastorakos, S Michalas.   

Abstract

New organ-specific functions of angiotensin II have recently been described: the importance of its role in the regulation of secretory epithelial function in many tissues including components of the reproductive tract has been documented. The source of angiotensin II in these tissues is the reproductive tract itself, and there is considerable evidence to suggest a distinct renin-angiotensin-aldosterone system in the ovary and uterus. Two main subtypes of angiotensin II receptors are recognized as angiotensin-receptor I and II, according to their sensitivity to the angiotensin II antagonists. However, the presence of angiotensin II receptors in the male and female reproductive tract suggests a multiplicity of roles that are unrelated to their primary functions or to each other. The renin-angiotensin-aldosterone system is a major determinant of sodium balance in pregnancy. More recently RT-PCR methods have revealed angiotensinogen transcription in the smooth muscle of spiral anteries of the decidua; a specific allele of this gene may be associated with hypertension in pregnancy as well as in pre-eclampsia. We investigated the evolution of plasma renin activity and aldosterone levels during normal and hypertensive pregnancy. Both were found to increase progressively during all three trimesters of normotensive pregnancy. Plasma renin activity in hypertensive women remained unchanged during all three trimesters of pregnancy. Plasma aldosterone levels in hypertensive women increased progressively during all three trimesters of pregnancy. However, plasma aldosterone levels remained significantly lower than the ones of normotensive pregnant women. These increased aldosterone levels were noticed despite unchanged renin levels. Further clinical studies investigating the renin-angiotensin-aldosterone system in the pathogenesis of pregnancy hypertension are needed. A renin-independent role of aldosterone in this pathological entity is suggested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818397     DOI: 10.1111/j.1749-6632.2000.tb06221.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Failure of fertility therapy and subsequent adverse cardiovascular events.

Authors:  Jacob A Udell; Hong Lu; Donald A Redelmeier
Journal:  CMAJ       Date:  2017-03-13       Impact factor: 8.262

2.  Changes in global gene expression during in vitro decidualization of rat endometrial stromal cells.

Authors:  Griselda Vallejo; Darío Maschi; Ana C Mestre-Citrinovitz; Kazuhiro Aiba; Ricardo Maronna; Victor Yohai; Minoru S H Ko; Miguel Beato; Patricia Saragüeta
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

Review 3.  Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention.

Authors:  Petal Elder; Garima Sharma; Martha Gulati; Erin D Michos
Journal:  Am J Prev Cardiol       Date:  2020-06-06

Review 4.  Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy.

Authors:  Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin; Gabriella Donà; Jacopo Manso; Filippo Ceccato; Carla Scaroni; Decio Armanini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-23       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.